Encompass Health Co. to Post FY2022 Earnings of $3.99 Per Share, William Blair Forecasts (NYSE:EHC)

Encompass Health Co. (NYSE:EHCGet Rating) – William Blair reduced their FY2022 earnings estimates for shares of Encompass Health in a research report issued to clients and investors on Tuesday, June 7th. William Blair analyst M. Larew now forecasts that the company will earn $3.99 per share for the year, down from their prior estimate of $4.05. William Blair also issued estimates for Encompass Health’s Q2 2023 earnings at $1.12 EPS and FY2023 earnings at $4.64 EPS.

Encompass Health (NYSE:EHCGet Rating) last issued its quarterly earnings results on Wednesday, April 27th. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.93 by $0.04. Encompass Health had a net margin of 7.51% and a return on equity of 17.99%. The company had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.32 billion. During the same quarter last year, the company posted $1.05 EPS. The firm’s revenue was up 8.4% compared to the same quarter last year.

A number of other analysts have also weighed in on the stock. TheStreet upgraded shares of Encompass Health from a “c+” rating to a “b-” rating in a research note on Tuesday, March 15th. Truist Financial lifted their price objective on shares of Encompass Health from $78.00 to $85.00 in a research report on Thursday, April 7th. StockNews.com cut Encompass Health from a “buy” rating to a “hold” rating in a research note on Friday. Royal Bank of Canada lowered their price objective on Encompass Health from $85.00 to $82.00 in a research report on Wednesday. Finally, Zacks Investment Research raised Encompass Health from a “sell” rating to a “hold” rating and set a $76.00 target price on the stock in a research report on Monday, April 11th. Two research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $81.44.

Shares of NYSE EHC opened at $58.33 on Friday. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.26 and a quick ratio of 1.26. The company has a market cap of $5.82 billion, a price-to-earnings ratio of 14.92, a price-to-earnings-growth ratio of 1.99 and a beta of 0.96. The stock’s 50-day moving average is $67.08 and its two-hundred day moving average is $65.80. Encompass Health has a 1-year low of $56.31 and a 1-year high of $85.75.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Whittier Trust Co. purchased a new stake in Encompass Health during the 4th quarter valued at approximately $26,000. Meeder Asset Management Inc. acquired a new position in Encompass Health in the 1st quarter valued at $33,000. Signaturefd LLC lifted its stake in shares of Encompass Health by 58.9% in the 4th quarter. Signaturefd LLC now owns 499 shares of the company’s stock worth $33,000 after acquiring an additional 185 shares during the period. Parallel Advisors LLC boosted its holdings in shares of Encompass Health by 103.1% in the fourth quarter. Parallel Advisors LLC now owns 532 shares of the company’s stock valued at $35,000 after acquiring an additional 270 shares in the last quarter. Finally, Worth Asset Management LLC acquired a new position in shares of Encompass Health during the first quarter worth about $35,000. Institutional investors and hedge funds own 91.70% of the company’s stock.

In other news, Director Kevin J. O’connor acquired 1,000 shares of Encompass Health stock in a transaction on Friday, May 6th. The stock was bought at an average price of $66.48 per share, for a total transaction of $66,480.00. Following the completion of the purchase, the director now owns 3,436 shares in the company, valued at $228,425.28. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.70% of the company’s stock.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 20th. Investors of record on Wednesday, July 13th will be paid a dividend of $0.28 per share. The ex-dividend date of this dividend is Tuesday, July 12th. This represents a $1.12 dividend on an annualized basis and a yield of 1.92%. Encompass Health’s dividend payout ratio is presently 28.64%.

About Encompass Health (Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Featured Stories

Earnings History and Estimates for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.